ETHealthWorld | April 4, 2023
Bengaluru: Dozee has raised $6 million as part of its Series A2 funding. The round saw the infusion of funds from Dozee’s existing investor base consisting of Prime Venture Partners, 3one4 Capital, YourNest VC, and new investors which include State Bank of India, J&A Partners Family Office, and Dinesh Mody Ventures (ex-JB Chemicals and Pharmaceuticals promoters – Sharan Asher & Pranabh Mody). Dozee has established a presence in over 380+ hospitals covering 50+ districts.
With this fresh funding, Dozee plans to expand further in the Indian market and invest more in its differentiated R&D capabilities. In addition, the funding will provide a springboard for the company’s global expansion.
“The current Series A2 fund-raise is a part of the company’s plan to further its reach to every nook and corner of the country and to begin the era of ‘Made in India’ products in the global market,” said Mudit Dandwate, CEO & Co-Founder, Dozee.